Although HCC resistance to SFB can be explained by the targeted activation of PI3K/Akt and RAS/RAF/ERK signaling pathways by IGF-1R, we cannot rule out the existence of other mechanisms, which need to be investigated in the future. Here, IGF1R is linked to hepatocellular carcinoma.